TSX:LOVEPersonal Products
Cannara Biotech (TSX:LOVE) Stock Faces Margin Decline As Net Profit Margin Falls To 9.3%
Cannara Biotech (TSX:LOVE) has reported Q3 2026 revenue of C$31.8 million, with basic EPS of C$0.049 and net income excluding extra items of C$4.8 million, setting a clear marker for this earnings season. The company has seen quarterly revenue move from C$27.1 million in Q2 2026 to C$31.8 million in Q3 2026, while basic EPS shifted from C$0.017 in Q2 to C$0.049 in Q3, giving investors fresh numbers to set against the recent year of growth and margin compression. With trailing 12 month revenue...